Theriva Biologics Inc (TOVX) Earning Prediction
Theriva Biologics Inc (TOVX) is set to release its earnings performance on 08/20 04:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of - and an earnings per share (EPS) of for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
TOVX Transcript
The earnings call indicates increased R&D expenses and declining cash reserves, with no new partnerships secured. The competitive market and economic uncertainties pose risks, and management's vague responses on partnerships and trial timelines add to concerns. Despite some promising trials, the lack of concrete progress or guidance, combined with financial challenges, suggests a negative stock reaction.
The earnings call reflects mixed signals: a significant decrease in G&A expenses and increased R&D spending indicate financial health, yet reliance on partnerships and external funding poses risks. The Q&A highlights potential in clinical trials, but management's vague responses on timelines raise uncertainties. No strong catalysts like partnerships or guidance changes were announced, leading to a neutral sentiment.
TOVX Report
Frequently Asked Questions
What is the Theriva Biologics Inc Earnings Release Date and Time?
Theriva Biologics Inc (TOVX) is scheduled to release its earnings report onAug 20, 2024, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Theriva Biologics Inc Revenue and EPS?
Analysts' consensus predicts 0.00 in revenue and an EPS of 0.00 for Theriva Biologics Inc's .
What Does Intellectia's AI Predict for Theriva Biologics Inc Earnings?
Intellectia's exclusive AI algorithms forecast a forTheriva Biologics Inc's earnings, with a prediction date of Aug 20, 2024. Theriva Biologics Inc
How Can I Use This Earnings Prediction to Trade TOVX Stock?
Leverage Intellectia's AI forecast to position trades ahead of theAug 20, 2024 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Theriva Biologics Inc ?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
